Table 1 Patient characteristics.
From: 5-Aminovaleric acid betaine predicts impaired glucose metabolism and diabetes
Characteristics | T-3 | T0 | T18 | |||
|---|---|---|---|---|---|---|
N | Values | N | Values | N | Values | |
Age (years) | 143 | 50.5 ± 12.6 | 143 | 50.8 ± 12.6 | 112 | 53.9 ± 12.2 |
Sex, N | 143 | |||||
Male | 31 | 21.5% | ||||
Female | 112 | 77.8% | ||||
BMI (kg/m2) | 143 | 37.3 ± 6.1 | 143 | 32.7 ± 5.7 | 112 | 33.3 ± 5.3 |
Glucose metabolism | 143 | 143 | 111 | |||
No diabetes | 87 | 60.4% | 98 | 68.1% | 51 | 35.4% |
Impaired GM | 38 | 26.4% | 29 | 20.3% | 45 | 31.3% |
Type 2 diabetes | 18 | 12.5% | 16 | 11.1% | 15 | 10.4% |
Diabetes medication | 144 | 144 | 144 | |||
No | 138 | 95.8% | 135 | 93.8% | 133 | 92.4% |
Yes | 6 | 4.2% | 9 | 6.3% | 11 | 7.6% |
Lean body mass (%) | 126 | 63.9 ± 6.3 | 134 | 67.8 ± 7.4 | 134 | 68.5 ± 7.9 |
Total abdominal body fat (mm²) | 143 | 54,592.7 ± 13,414.5 | 143 | 43,838.1 ± 12,817.6 | 107 | 44,916.1 ± 11,391.4 |
HbA1c (%) | 143 | 5.8 ± 0.8 | 143 | 5.9 ± 0.8 | 106 | 5.6 ± 0.6 |
ISI | 140 | 0.06 ± 0.03 | 140 | 0.08 ± 0.04 | ||
HOMA | 142 | 2.9 ± 2.7 | 143 | 1.6 ± 1.0 | 109 | 2.1 ± 1.5 |
Disposition index | 138 | 0.6 ± 0.3 | 141 | 0.4 ± 0.2 | 110 | 0.5 ± 0.3 |
Insulin secretion (A.U.) | 138 | 0.57 ± 0.30 | 141 | 0.38 ± 0.20 | 110 | 0.44 ± 0.23 |
Fatty liver index | 141 | 81.0 ± 18.6 | 143 | 54.7 ± 28.7 | 101 | 61.4 ± 26.3 |
Live fat score | 141 | 0.3 ± 2.2 | 143 | −1.1 ± 1.4 | 107 | −0.7 ± 1.7 |
5-AVAB (log) | 143 | 7.5 ± 0.15 | 143 | 7.4 ± 0.10 | ||
